Evidence map›Paper›PMID 34899732›Full record

ArticleFrontiers in immunology2021

Subunit-Specific Reactivity of Autoantibodies Against Laminin-332 Reveals Direct Inflammatory Mechanisms on Keratinocytes.

Lei Bao, Jing Li, Farzan Solimani, Dario Didona, Payal M Patel, Xiaoguang Li, Hua Qian, Norito Ishii, Takashi Hashimoto, Michael Hertl and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Challenges and advances in ocular mucous membrane pemphigoid (OMMP); from pathogenesis to treatment strategies.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2025
    Review
  5. Review
  6. Review
  7. Review
  8. Autoimmunity against laminin 332.Frontiers in immunology · 2023
    Review
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 4 countries.

Lei BaoDepartment of Dermatology, University of Illinois at Chicago, Chicago, IL, United States.
Jing LiDivision of Dermatology, Rush University Medical Center, Chicago, IL, United States.
Farzan SolimaniDepartment of Dermatology and Allergology, Philipps University, Marburg, Germany.
Dario DidonaDepartment of Dermatology and Allergology, Philipps University, Marburg, Germany.
Payal M PatelDivision of Dermatology, Rush University Medical Center, Chicago, IL, United States.
Xiaoguang LiCentral Laboratory, Dermatology Hospital of Jiangxi Province, Dermatology Institute of Jiangxi Province, and the Affiliated Dermatology Hospital of Nanchang University, Nanchang, China.
Hua QianCentral Laboratory, Dermatology Hospital of Jiangxi Province, Dermatology Institute of Jiangxi Province, and the Affiliated Dermatology Hospital of Nanchang University, Nanchang, China.
Norito IshiiDepartment of Dermatology, Kurume University School of Medicine, and Kurume University Institute of Cutaneous Cell Biology, Kurume, Japan.
Takashi HashimotoDepartment of Dermatology, Kurume University School of Medicine, and Kurume University Institute of Cutaneous Cell Biology, Kurume, Japan.
Michael HertlDepartment of Dermatology and Allergology, Philipps University, Marburg, Germany.
Kyle T AmberDivision of Dermatology, Rush University Medical Center, Chicago, IL, United States.
Rush University Medical Center · USNanchang University · CNPhilipps University of Marburg · DECharité - Universitätsmedizin Berlin · DEKurume University · JPOsaka City University · JPUniversity of Illinois Chicago · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Laminin-332 pemphigoid is a rare and severe autoimmune blistering disease, caused by IgG autoantibodies targeting laminin-332 in the dermal-epidermal basement zone. Laminin-332 pemphigoid is characterized by variable inflammatory infiltrate and the predominance of non-complement-fixing antibodies. Given these findings, we hypothesized that IgG autoantibodies to laminin-332 directly resulted in keratinocyte expression of inflammatory factors. We performed RNA-seq on primary human keratinocytes treated with IgG from patients with laminin-332 pemphigoid. Genes for numerous cytokines and chemokines were upregulated, including CSF2, CSF3, CXCL1, CXCL5, CXCL3, CXCL8, CXCL10, CXCL1, IL6, IL7, IL15, IL23, IL32, IL37, TGFB2 as well as metalloproteases. Considering the pro-inflammatory and proteolytic effect of autoantibodies from patients with laminin-332 pemphigoid identified in our initial experiment, we next questioned whether the reactivity against specific laminin subunits dictates the inflammatory and proteolytic keratinocyte response. Then, we treated keratinocytes with IgG from a separate cohort of patients with reactivity against individual subunits of laminin-332. We identified upregulation of IL-1α, IL-6, IL-8, CXCL1, MMP9, TSLP, and GM-CSF at the protein level, most notably in keratinocytes treated with IgG from laminin β3-reactive patients. We for the first time demonstrated a pro-inflammatory response, similar to that described in keratinocytes treated with IgG autoantibodies from patients with bullous pemphigoid, providing novel insight into the pathogenesis of laminin-332 pemphigoid and laminin-332 biology.

Indexed as

AgedAged, 80 and overAntibody SpecificityAutoantibodiesAutoantigensCell Adhesion MoleculesCells, CulturedCytokinesEpidermisFemaleGene Expression ProfilingHumansImmunoglobulin GInflammation MediatorsKalininKeratinocytesAutoantibodiesAutoantigensCell Adhesion MoleculesCytokinesImmunoglobulin GInflammation MediatorsKalininautoimmune blistering diseasesimmunobullous diseasekeratinocytelaminin-332 pemphigoidRNA-seq

Identifiers

PMID34899732
PMCPMC8655097
OpenAlexW3215384545

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.